OpinionTrump is a ‘wild card’ for the stock market, this trader says. He’s buckling up. Jan. 21, 2025 at 7:04 a.m. ETby Michael Sincere Biotech and PharmaMedicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out. ...
Get the latest Pfizer Inc. (PFE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
PFE Key Statistics Market cap 144.68B Price-Earnings ratio 18.12 Dividend yield 6.62% Average volume 42.22M High today $26.45 Low today $25.47 Open price $25.71 Volume 33.21M 52 Week high $31.54 52 Week low $24.48 PFE News TipRanks 3dStarboard Value buys Pfizer, exits Humana in Q4 Jeffrey...
healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq gold bitcoin market outlook today's market us economy gold & precious metals commodities forex editors...
Here’s Why and 5 Other Things to Know Today. 6:29a Simple 60/40 portfolio would’ve easily beaten hedge-fund returns last year 6:14a Barron's Bitcoin Price Stalls. Why Inflation Data Matter for Crypto. 6:07a Barron's Nvidia Stock Slips. Why This Analyst Is Lowering Revenue ...
So, is Pfizer stock a buy or a sell today? Pfizer Stock Fundamentals In the September quarter, Pfizer earned an adjusted $1.06 per share on $17.7 billion in sales. Both beat the Street's forecast. Earnings reversed from a year-earlier loss, while sales climbed 31%. In addition to the ...
Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out. Jan. 14, 2025 7:11 a.m. ET Trump Looms Large Over Stock Markets. Why Chips, Fed Are Just the Beginning and 5 Other Things to Know Today. ...
PFIZER:NSI Actions Health CarePharmaceuticals and Biotechnology Price (INR)4,423.30 Today's Change-146.75 / -3.21% Shares traded22.01k 1 Year change+2.99% Beta0.4731 Data delayed at least 15 minutes, as of Jan 28 2025 10:01 GMT. Participate in the 2025 Stockpicking Contest ...
Wells Fargo analyst Mohit Bansal maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $27.00. The company...
We rate Pfizer market-perform, with a price target of $23. While we have serious concerns around Pfizer's various fundamental challenges and its ability to grow its revenue base, its current historically low P/E multiple appears to discount many of these issues already. Pfizer's long-term ...